Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Blanco

Showing results (511-520 of 530) with videos related to

Pageof 53
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|April 29, 2009
A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppressionEsteban Martínez, José A Arranz, Daniel Podzamczer, et al.
Molecular Oncology|June 21, 2022
Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemiaMireia Ramos-Muntada, Juan L Trincado, Joan Blanco, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 18, 2024
Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV: A cross-sectional population-based studyElisa de Lazzari, Daniel K Nomah, Jose L Blanco, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2023
Efficacy and safety of raltegravir plus lamivudine maintenance therapyBeatriz Borjabad, Alexy Inciarte, Ivan Chivite, et al.
Cancer Medicine|July 5, 2023
Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletionMartín I Castillo, Villamón E Ribate, Calabuig M Muñoz, et al.
Ophthalmology|February 22, 2023
Characteristics and Management of Ocular Involvement in Individuals with Monkeypox DiseaseMarta Pazos, Josep Riera, Aina Moll-Udina, et al.
European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [Et Al] = Zeitschrift Fur Kinderchirurgie|November 26, 2025
Age-Stratified Impact of Early Virtual Reality Intervention on Preoperative Anxiety in Children: A Randomized TrialGloria Chocarro Amatriain, Teresa M Cardenal Alonso-Allende, Olga Olivas Gallego, et al.
The New England Journal of Medicine|July 22, 2022
Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022John P Thornhill, Sapha Barkati, Sharon Walmsley, et al.
The Lancet. HIV|June 9, 2025
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trialPablo Ryan, José L Blanco, Mar Masia, et al.
Science Advances|July 10, 2021
Global homogenization of the structure and function in the soil microbiome of urban greenspacesManuel Delgado-Baquerizo, David J Eldridge, Yu-Rong Liu, et al.
Pageof 53

Showing results (511-520 of 530) with videos related to

Sort By:
Pageof 53
Journal of Acquired Immune Deficiency Syndromes (1999)|April 29, 2009
A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppressionEsteban Martínez, José A Arranz, Daniel Podzamczer, et al.
Molecular Oncology|June 21, 2022
Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemiaMireia Ramos-Muntada, Juan L Trincado, Joan Blanco, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 18, 2024
Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV: A cross-sectional population-based studyElisa de Lazzari, Daniel K Nomah, Jose L Blanco, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2023
Efficacy and safety of raltegravir plus lamivudine maintenance therapyBeatriz Borjabad, Alexy Inciarte, Ivan Chivite, et al.
Cancer Medicine|July 5, 2023
Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletionMartín I Castillo, Villamón E Ribate, Calabuig M Muñoz, et al.
Ophthalmology|February 22, 2023
Characteristics and Management of Ocular Involvement in Individuals with Monkeypox DiseaseMarta Pazos, Josep Riera, Aina Moll-Udina, et al.
European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [Et Al] = Zeitschrift Fur Kinderchirurgie|November 26, 2025
Age-Stratified Impact of Early Virtual Reality Intervention on Preoperative Anxiety in Children: A Randomized TrialGloria Chocarro Amatriain, Teresa M Cardenal Alonso-Allende, Olga Olivas Gallego, et al.
The New England Journal of Medicine|July 22, 2022
Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022John P Thornhill, Sapha Barkati, Sharon Walmsley, et al.
The Lancet. HIV|June 9, 2025
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trialPablo Ryan, José L Blanco, Mar Masia, et al.
Science Advances|July 10, 2021
Global homogenization of the structure and function in the soil microbiome of urban greenspacesManuel Delgado-Baquerizo, David J Eldridge, Yu-Rong Liu, et al.
Pageof 53